Skip to main content
Log in

TDM-guided screening for primary aldosteronism cost saving

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. PA screening tests included plasma renin activity, serum aldosterone levels, followed by IV saline suppression tests to confirm the diagnosis, and adrenal vein sampling and computed tomography of adrenal glands in patients with positive saline suppression test results

  2. 2013 US dollars

Reference

  • Velasco A, et al. Cost-Effectiveness of Therapeutic Drug Monitoring in Diagnosing Primary Aldosteronism in Patients With Resistant Hypertension. Journal of Clinical Hypertension (Greenwich) : 27 Apr 2015. Available from: URL: http://doi.org/10.1111/jch.12570

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

TDM-guided screening for primary aldosteronism cost saving. PharmacoEcon Outcomes News 727, 30 (2015). https://doi.org/10.1007/s40274-015-2114-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2114-x

Navigation